Nachrichten zur Sanofi S.A. Aktie

Sanofi Scores FDA Approval For Flu-Shot Facility In US

CytoReason Collaborates with Sanofi, Using its AI Technology to Gain Better Understanding of Disease Mechanisms

TEL AVIV, Israel, June 17, 2021 /PRNewswire/ -- CytoReason, an AI company developing a computational disease model of the human…

Sanofi Hold

HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat die Einstufung für Sanofi auf "Hold" mit einem Kursziel von 92 Euro…

CFO Evelyne Freitag verlässt Sanofi Deutschland

Der Pharmakonzern Sanofi bekommt einen neuen CFO in Deutschland. Evelyne Freitag hat ihr Amt mit sofortiger Wirkung niedergelegt. Für sie…

Finanzchefin Freitag verlässt Sanofi Deutschland

Nach vier Jahren zieht sich Evelyne Freitag aus dem Pharmakonzern Sanofi zurück. Ihr Nachfolger als der für Finanzen zuständige Geschäftsführer…

Sanofi buy

NEW YORK (dpa-AFX Analyser) - Die US-Investmentbank Goldman Sachs hat Sanofi anlässlich der jährlichen, bankeigenen weltweiten Gesundheitskonferenz auf "Buy" mit…

Sanofi SA (SNY) Presents at Goldman Sachs 42nd Annual Global Healthcare Conference (Transcript)

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Sanofi Outperform

ZÜRICH (dpa-AFX Analyser) - Die schweizerische Bank Credit Suisse hat die Einstufung für Sanofi anlässlich der Krebskonferenz Asco auf "Outperform"…

Sanofi Launches Global Employee Share Ownership Plan

PARIS (dpa-AFX) - Sanofi has launched its global employee share ownership plan, which will open to 92,000 employees in 73…

Sanofi launches its new global employee share ownership plan

Attachment...…

Sanofi (SNY) Management Presents on 2021 American Society of Clinical Oncology (ASCO) Annual Meeting Conference (Transcript)

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Sanofi buy

NEW YORK (dpa-AFX Analyser) - Die US-Investmentbank Jefferies hat die Einstufung für Sanofi auf "Buy" mit einem Kursziel von 110…

Sanofi (SNY) Presents At 2021 American Society of Clinical Oncology Annual Meeting - Slideshow

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Sanofi Inks Partnership for Late-Stage Trial of Amcenestrant as Add-On Breast Cancer Therapy

The Daily Biotech Pulse: Merck, AstraZeneca, Novartis Among Early Presenters At ASCO, Sanofi Strikes Breast Cancer Study Pact

Heres a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week…

Studie - Corona-Krise lässt Chef-Gehälter in Europa einbrechen

München (Reuters) - Die Gehälter der Vorstandschefs von Europas wichtigsten Unternehmen sind in der Corona-Krise auf den niedrigsten Stand der…

Sanofi Partners With Academic Cooperative Groups To Study Amcenestrant In Breast Cancer

PARIS (dpa-AFX) - Sanofi (SNYNF, SNY) said that it has partnered with academic cooperative groups to initiate a pivotal trial…

Sanofi teams up with research groups to study amcenestrant in patients with ER+ breast cancer

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Sanofi partnering with leading academic cooperative groups to study amcenestrant in the adjuvant setting for patients with estrogen receptor positive breast cancer

PARIS, June 4, 2021 /PRNewswire/ -- Sanofi is partnering with leading groups delivering practice-changing breast cancer research, the Breast International…

Sanofi partnering with leading academic cooperative groups to study amcenestrant in the adjuvant setting for patients with estrogen receptor positive breast cancer

Sanofi partnering with leading academic cooperative groups to study amcenestrant in the adjuvant setting for patients with estrogen receptor positive…

White House to allow AstraZeneca, Novavax, Sanofi to distribute COVID-19 shots how they see fit

The White House said Thursday that it removed a requirement that is part of the Defense Production Act that gives…

U.S. Influenza (Flu) Vaccines Market Report 2021: EpiVax to Design Antigens for Next-Generation Flu Vaccine - Key Players are Sanofi Pasteur, GlaxoSmithKline, Seqirus & AstraZeneca

DUBLIN, June 3, 2021 /PRNewswire/ -- The "U.S. Influenza (Flu) Vaccines Market - Growth, Demand, Trends, Opportunity, Forecasts (2021 -…

Global Generic Drugs Markets, 2020-2021 & Forecast to 2025: Leading Players are Aspen, Cipla, Lupin, Pfizer, Sanofi, Sun Pharmaceuticals and Teva Pharmaceuticals

DUBLIN, June 2, 2021 /PRNewswire/ -- The "Global Generic Drugs Market 2020-2025" report has been added to ResearchAndMarkets.coms offering. The…

Sanofi add

MÜNCHEN (dpa-AFX Analyser) - Die Baader Bank hat die Einstufung für Sanofi mit Blick auf Spekulationen über eine Fusion mit…

JD HEALTH, Sanofi Strike Strategic Upgrade Partnership for Digital Healthcare Ecosystem

JD HEALTH (06618.HK) announced its strategic upgrade partnership with Sanofi China for digital healthcare ecosystem. Accordingly, both sides will come…

Sanofi (SNY) Stops Venglustat Development as Kidney Cyst Drug

Sanofi (SNY) discontinues development of pipeline candidate, venglustat, in patients with autosomal dominant polycystic kidney disease, following failure in a…

P/E Ratio Insights for Sanofi

Sanofi, Merck Announce Availability Of Six-in-one Pediatric Combination Vaccine Vaxelis In The U.S.

KENILWORTH (NJ) (dpa-AFX) - French drug maker Sanofi (SNY) and Merck & Co. (MRK), known as MSD outside the U.S.…

Sanofi buy

NEW YORK (dpa-AFX Analyser) - Die US-Investmentbank Goldman Sachs hat die Einstufung für Sanofi nach einem Studienrückschlag auf "Buy" mit…

Sanofi stoppt Venglustat-Studienprogramm bei Zystennieren

FRANKFURT (Dow Jones)--Sanofi hat die klinische Erprobung seines neuen Wirkstoffs Venglustat zur Behandlung von Zystennieren (Autosomal-Dominante Polyzystische Nierenerkrankung, ADPKD) gestoppt.…

Sanofi Halts Clinical Program In ADPKD As Venglustat Trial Failed To Meet Futility Criteria

PARIS (dpa-AFX) - French drug maker Sanofi (SNY) announced Tuesday that a pivotal Phase 2/3 study of venglustat in autosomal…

Sanofi provides update on venglustat clinical program

Sanofi provides update on venglustat clinical program...…

Sanofi: Information concerning the total number of voting rights and shares - April 2021

...…

Sanofi and GlaxoSmithKline begin Phase 3 study of COVID-19 vaccine candidate

French pharmaceutical group Sanofi [s:fr: san] and U.K. drug company GlaxoSmithKline said they have begun global Phase 3 efficacy…

New Covid-19 Vaccine Will Be Produced This Year As Sanofi, GSK Launch Phase 3 Trial

One part of the trial will test the vaccine against the South African variant of the virus....…

GlaxoSmithKline, Sanofi begin phase 3 study of Covid-19 vaccine

Um den gesamten Artikel unter stockmarketwire.com zu lesen, klicken Sie bitte auf die Überschrift...…

Sanofi, GSK Initiate Phase 3 Clinical Efficacy Study Of COVID-19 Vaccine Candidate

LONDON (dpa-AFX) - GlaxoSmithKline PLC (GSK.L, GSK) and French drug maker Sanofi (SNY) announced Thursday that they have started enrollment…

Sanofi und Glaxo starten klinische Studie zu Corona-Impfstoff

Von Pietro Lombardi PARIS (Dow Jones)--Die Pharmakonzerne Sanofi SA und Glaxosmithkline plc beginnen mit groß angelegten klinischen Studien ihres…

Sanofi, GSK initiate Phase 3 study of COVID-19 vaccine candidate

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

UPDATE 1-Sanofi, GSK launch Phase III trial for their COVID-19 shot

...(Adds details) PARIS, May 27 (Reuters) - Frances Sanofi......…

TOP NEWS: GSK and Sanofi launch phase three study for Covid vaccine

Um den gesamten Artikel unter morningstar.co.uk zu lesen, klicken Sie bitte auf die Überschrift...…

Sanofi, GSK launch Phase III trial for their COVID-19 shot

...PARIS (Reuters) - Sanofi and GlaxoSmithKline said on Thursday......…

Sanofi and GSK initiate global Phase 3 clinical efficacy study of COVID-19 vaccine candidate

Sanofi and GSK initiate global Phase 3 clinical efficacy study of COVID-19 vaccine candidate...…

Sanofi, Walvax COVID-19 Vaccine Phase 3 Trials to Commence in Mexico: Reuters

UPDATE 1-Mexico to begin phase three trials of Sanofi, Walvax COVID-19 vaccines

...(Adds quotes, more details) MEXICO CITY, May 24 (Reuters) - Mexico......…

Mexico to host phase three trials of Sanofi COVID-19 vaccine - foreign min

...MEXICO CITY (Reuters) - Mexico Foreign Minister Marcel Ebrard......…

The Zacks Analyst Blog Highlights: Cisco Systems, Sanofi, Charles Schwab, Target and ConocoPhillips

The Zacks Analyst Blog Highlights: Cisco Systems, Sanofi, Charles Schwab, Target and ConocoPhillips...…

The Zacks Analyst Blog Highlights: Sanofi, GlaxoSmithKline, Pfizer, Eli Lilly and Merck

The Zacks Analyst Blog Highlights: Sanofi, GlaxoSmithKline, Pfizer, Eli Lilly and Merck...…

Sanofi: Underestimated Vaccine Potential

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Top Analyst Reports for Cisco, Sanofi & Charles Schwab

Top Analyst Reports for Cisco, Sanofi & Charles Schwab...…